The Complete 2012-13 Induced Pluripotent Stem Cell Industry Report - Market Metrics, Dynamics, and Trends

1
Aarkstore.com The Complete 2012-13 Induced
Pluripotent Stem Cell Industry Report - Market
Metrics, Dynamics, and Trends
2
Summary

• BioInformant Worldwide, LLC, has recently
  released the market intelligence report titled
  The Complete 2012-13 Induced Pluripotent Stem
  Cell Industry Report - Market Metrics, Dynamics,
  and Trends. It provides strategic insights that
  guide the decision-making of companies that
  develop and manufacture induced pluripotent stem
  cell (iPSC) research products.
• The market intelligence report presents financial
  metrics for the Induced Pluripotent Stem Cell
  Industry, as well as key findings discovered from
  surveying a global audience of iPSC researchers
  (293 respondents). It reveals iPSC product and
  industry trends with five-year projections
  informs about iPSC grants, patents and
  publications identifies profitable opportunities
  for producers of iPSC products, and presents
  critical insights into future tools that iPSC
  scientists will require. In addition, it clearly
  denotes preferred species for iPSC research,
  analyzes the competitive environment for iPSC
  research products, and breaks down market share
  by competitor providing an overall view of the
  iPSC product landscape.
• iPSCs are adult stem cells that have been
  transformed into embryotic-like stem cells
  through the manipulation of gene expression and
  similar methods. Despite some initial concerns,
  induced pluripotent stem cells (iPSC) are now
  sold by more than half (53.4) of U.S. research
  product companies and 38.7 of research product
  companies worldwide.

3

• "It is clear that iPSC products are in high
  demand within the scientific community.
  Currently, it is difficult for stem cell research
  product suppliers, like BD BioSciences, Life
  Technologies, and others, to know what products
  iPSC scientists will demand in 2013 and beyond.
  The needs of scientists are constantly changing,
  so this market intelligence report reveals
  profitable opportunities for providers of iPSC
  research products to pursue, says BioInformant.
• For the past five decades, stem cell research has
  provided insights to the inner workings of the
  body and cell regeneration. Therapeutic
  applications of iPSCs represent the future of
  medicine," says BioInformant. The scientific
  community believes that one day stem cell
  research will assist in finding viable treatments
  for crippling diseases such as Parkinsons,
  Alzheimers, spinal cord injuries and more.
• This is a must-read industry report for research
  supply companies to optimally position themselves
  to sell iPSC research products. This is a
  lucrative and rapidly expanding market, explains
  BioInformant.  The study will help you
  understand your key strengths relative to the
  competition.
• The study is backed by a 100 money back
  guarantee, to ensure that the strategies,
  findings and tools are found helpful.

4

• To learn more about The Complete 2012-13 Induced
  Pluripotent Stem Cell Industry Report - Market
  Metrics, Dynamics, and Trends, please visit
  http//www.aarkstore.com/reports/The-Complete-2012
  -13-Induced-Pluripotent-Stem-Cell-Industry-Report-
  Market-Metrics-Dynamics-and-Trends-231968.html
• for details.
• OR Contact
• Vina
• Aarkstore.com
• Contact Marketing team
• Mob.No.918149852585
• Email enquiry_at_aarkstore.com
• URL http//www.aarkstore.com/